CSF1R and glioma: CSF1–CSF1R signaling sustains TAM viability and skews polarization; in proneural glioma models, CSF1R blockade remodels rather than depletes TAMs and attenuates tumor growth, highlighting circuitry that can be pharmacologically reprogrammed (11–13).